In stage II colon cancer with high CD206/CD68 ratio, adjuvant chemotherapy significantly improved the DFS rate from 38.9 to 68.0% at 3 years and from 33.1 to 66.0% at 5 years (124). The gene discussed is MRC1; the disease is colonic neoplasm.